ATLANTA, Jan. 31, 2023 /PRNewswire/ — Mikart, LLC –a comprehensive contract development and manufacturing organization announced the completion of a new liquids and suspensions suite in Atlanta, Georgia. The investment is in response to clients’ demand to provide expert contract services to develop robust, reliable liquid dosage forms. Mikart’s clients now have access to a variety of temperature controlled tanks that support a wide diversity of volumes ranging from 4,000L to 50L to volumes. This investment further supports our growing geriatric and pediatric product development and manufacturing capabilities.
The facility suite will be capable of manufacturing complex suspension products, including extended release products.
Michael Kallelis, Chief Executive Officer at Mikart, added, “The new capabilities enhance our support of early to late-stage formulation development, enabling clients to quickly scale-up to GMP manufacture of clinical trial materials. This added capability will expedite the development process and further differentiate Mikart’s CDMO services in the small molecule space.”
Gus LaBella, Director of Formulation Development, commented, “Manufacturing suspensions can be quite difficult on a large scale. Mikart has performed extensive testing in this suite and the adjacent packaging area to ensure product quality is maintained from start to finish.”
“We continue to see strong demand for liquid and suspension products across several indications,” commented Nazar Elkarim, PhD Vice President of Product Development Services at Mikart. “These investments will enable us to expand our capabilities, and offer greater agility for our customers.”
About Mikart, LLC
Mikart, LLC is a privately held contract development and manufacturing organization (CDMO) founded in 1975. Mikart focuses on small molecules, potent compounds, solid oral, combination products, suspensions, liquids, and serialized packaging services. The company has a full range of formulation, analytical, packaging and manufacturing services with a seamless development solution that minimizes the time-to-market from clinical work through commercial supply. Follow us on LinkedIn to stay informed https://www.linkedin.com/company/mikart-llc/ or for more information visit us at https://www.mikart.com/.
CONTACT: Michelle Hall, [email protected]